Edwards Jeffrey B, Wooster Mathew D, Tanious Adam, Back Martin R
Department of Vascular Surgery, University of South Florida, Tampa, FL.
Department of Vascular Surgery, Medical University of South Caroline, Charleston, SC.
Ann Vasc Surg. 2019 Jan;54:110-117. doi: 10.1016/j.avsg.2018.05.058. Epub 2018 Aug 4.
Renal artery anomalies occur at a rate of 1-2% and present a challenge to vascular surgeons performing aortic surgery. We describe adjuncts used to manage such anatomic variants.
A single surgeon registry of all abdominal aortic aneurysms repaired in an academic center was retrospectively reviewed. Patients with prior renal transplants, congenital pelvic kidneys, or horseshoe kidneys were included. Open repair was reserved for patients with no endovascular or hybrid repair options.
Over an 8-year period, 18 patients were identified (renal transplant n = 9, horseshoe kidney n = 3, congenital pelvic kidney n = 6). All transplant patients were treated with endovascular repair. Four required cross-femoral bypasses, 1 for retrograde allograft perfusion after aorto-uni-iliac (AUI) procedure to the contralateral external iliac artery and 3 for contralateral limb perfusion after endograft extension into iliac artery ipsilateral to allograft. Three transplant patients required carotid access due to severe iliofemoral occlusive disease or allograft origin off the internal iliac artery. Two horseshoe kidney patients underwent open repair with direct reimplantation of accessory renal arteries, whereas 1 underwent endovascular repair with exclusion of an isthmus branch. Of the congenital single/pelvic kidney cohort, 2 underwent open repair with renal reimplantation, 2 underwent endovascular aneurysm repair, 1 was treated with AUI and cross-femoral bypass, and one was treated with a staged iliorenal bypass and subsequent fenestrated endovascular repair. Intravascular ultrasound was used to minimize contrast use in patients with chronic renal insufficiency (Cr > 1.5 mg/dL, n = 6). Over a mean follow-up of 31 months (range, 1-110), there were no aortic deaths or reintervention, no decline in renal function (measured by serum creatinine and glomerular filtration rate), and 100% patency of the preserved renal arteries.
Atypical renal anatomy should not preclude repair of aortic aneurysms. Repair of such aneurysms is safe and achieves good long-term outcomes with the use of the described techniques.
肾动脉异常的发生率为1% - 2%,给进行主动脉手术的血管外科医生带来了挑战。我们描述了用于处理此类解剖变异的辅助方法。
回顾性分析了在一个学术中心修复的所有腹主动脉瘤的单外科医生登记资料。纳入有肾移植史、先天性盆腔肾或马蹄肾的患者。对于没有血管内或杂交修复选择的患者则采用开放修复。
在8年期间,共确定了18例患者(肾移植9例,马蹄肾3例,先天性盆腔肾6例)。所有移植患者均接受了血管内修复。4例需要股交叉旁路手术,1例用于在主动脉 - 单侧 - 髂动脉(AUI)手术后对移植肾逆行灌注至对侧髂外动脉,3例用于在移植物延伸至移植肾同侧髂动脉后对侧肢体灌注。3例移植患者因严重的髂股闭塞性疾病或移植肾起源于髂内动脉而需要颈动脉入路。2例马蹄肾患者接受了开放修复并直接重新植入副肾动脉,而1例接受了血管内修复并排除了峡部分支。在先天性单/盆腔肾队列中,2例接受了开放修复并进行了肾重新植入,2例接受了血管内动脉瘤修复,1例接受了AUI和股交叉旁路手术,1例接受了分期髂肾旁路手术及随后的开窗血管内修复。对于慢性肾功能不全(肌酐>1.5mg/dL,n = 6)的患者,使用血管内超声以尽量减少造影剂的使用。平均随访31个月(范围1 - 110个月),无主动脉死亡或再次干预,肾功能无下降(通过血清肌酐和肾小球滤过率测量),保留的肾动脉通畅率为100%。
非典型肾解剖结构不应妨碍主动脉瘤的修复。使用所述技术修复此类动脉瘤是安全的,并能取得良好的长期效果。